ArticleCell communication and signaling : CCS2026

Correction: Harnessing nanomedicine to target NFκB signalling in cancer: at the intersection of inflammatory signalling, metabolic reprogramming, and therapeutic innovation.

Bandari BharathwajChetty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.